Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Ergonomic Training With or Without Structured Exercise in Oil Industry Workers With Chronic Musculoskeletal Pain

11 de novembro de 2026 atualizado por: Doç.Dr.Ömer Şevgin, Uskudar University

Effect of Structured Exercise Added to Ergonomic Training on Pain, Pain-Related Disability and Quality of Life in Oil Industry Workers With Chronic Musculoskeletal Disorders: A Randomized Controlled Trial

This randomized controlled trial will investigate whether a 12-week structured exercise program added to ergonomic training reduces pain and pain-related disability and improves quality of life more than ergonomic training alone in oil industry workers with chronic musculoskeletal pain. Forty workers aged 25-50 years with musculoskeletal pain lasting at least 3 months will be randomly assigned to either ergonomic training plus exercise or ergonomic training only. Both groups will receive two 45-minute ergonomic training sessions specific to oil-field work (weeks 1 and 6) and a printed brochure. The exercise group will additionally perform a phased neuromuscular and resistance exercise program 3 days per week for 12 weeks, partly supervised at the worksite and partly home/worksite-based. Pain intensity (visual analogue scale), pain-related disability (Pain Disability Index), quality of life (SF-12), regional musculoskeletal symptoms (Extended Nordic Musculoskeletal Questionnaire) and sleep quality (Pittsburgh Sleep Quality Index) will be assessed by an assessor blinded to group allocation at baseline and after 12 weeks.

Visão geral do estudo

Descrição detalhada

Background: Work-related musculoskeletal disorders are a leading cause of lost productivity and disability. Oil and gas installations combine heavy lifting, repetitive work, awkward postures, vibrating tools, prolonged standing and shift work; musculoskeletal symptom prevalence of 71-89% has been reported in this workforce. Multicomponent workplace programs combining exercise, ergonomics and education provide the most consistent benefit for pain and function, and ergonomic-educational interventions alone have reduced symptoms in oil and gas workers; however, no randomized controlled trial has evaluated the added value of exercise in this population.

Design: Prospective, assessor-blinded, two-arm, parallel-group, 1:1 randomized controlled trial conducted at a single oil industry facility. The study will be reported according to CONSORT and TIDieR. Participants will be randomized using a computer-generated list with variable block sizes (4 and 6); allocation will be concealed in sequentially numbered, opaque, sealed envelopes prepared by an investigator not involved in treatment or assessment.

Interventions: Both groups receive ergonomic training specific to oil-field work: two 45-minute face-to-face group sessions (8-12 workers) at weeks 1 and 6 covering musculoskeletal risk factors, NIOSH lifting principles, valve/flange and overhead work, hand-arm and whole-body vibration, prolonged standing and grated floors, control-room/office ergonomics, shift work and sleep hygiene, and a 5-minute micro-break routine, plus a printed brochure and micro-break card, with weekly reminder messages for 12 weeks. The exercise group additionally performs a 12-week structured program, 3 non-consecutive days per week, 45 minutes per session (36 sessions): weeks 1-2 fully supervised at the facility in groups of 4-6, weeks 3-12 one supervised and two home/worksite-based sessions per week supported by an illustrated brochure and guided video. Each session comprises warm-up and mobility (6 min), neuromuscular stabilization (12 min), resistance strengthening with elastic bands and light loads (14 min), job-specific functional exercise such as box lifting and carrying (6 min) and stretching (7 min). The program progresses through three phases (motor control and activation, weeks 1-4; endurance and strength, weeks 5-8; job-specific functional loading, weeks 9-12) with intensity targeted at Borg CR-10 4-6 and load progression by the 2-for-2 rule. The control group receives weekly ergonomic reminder messages and a telephone call every 2 weeks to equalize contact; the exercise program is offered to the control group after final assessment.

Outcomes: Assessments at baseline (T0) and at the end of the 12-week intervention (T1) by a physiotherapist blinded to group allocation. Primary outcome: pain intensity on a 0-10 cm visual analogue scale. Secondary outcomes: Pain Disability Index (0-70), SF-12 physical and mental component summaries, regional symptom prevalence on the Extended Nordic Musculoskeletal Questionnaire, and sleep quality on the Pittsburgh Sleep Quality Index (exploratory). Process measures: session adherence, Borg CR-10 and adverse events.

Sample size: A priori power analysis (G*Power 3.1; repeated-measures ANOVA, within-between interaction; f = 0.25, alpha = 0.05, power = 0.80, 2 groups, 2 measurements, correlation 0.50) indicated 34 participants; allowing for 15-20% attrition, 40 participants (20 per group) will be enrolled.

Analysis: Intention-to-treat with multiple imputation; per-protocol (adherence ≥70%) as sensitivity analysis. Primary outcome analyzed with 2 × 2 mixed-design repeated-measures ANOVA (group × time interaction) or ANCOVA on the week-12 score adjusted for baseline. Secondary continuous outcomes analyzed in the same way; Benjamini-Hochberg correction for secondary outcomes. Dichotomous Nordic data analyzed with McNemar and chi-square/Fisher tests. Effect sizes (partial eta squared, Cohen d) with 95% CIs, proportion exceeding the minimal clinically important difference and number needed to treat will be reported. Significance p < 0.05.

Tipo de estudo

Intervencional

Inscrição (Estimado)

40

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

25 anos a 50 anos (Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Age 25-50 years
  • Employed in the oil industry for at least 5 years
  • Musculoskeletal pain lasting at least 3 months, with symptoms in at least one body region in the last 12 months and the last 7 days on the Nordic Musculoskeletal Questionnaire
  • Pain intensity ≥3/10 on the visual analogue scale
  • Literate and able to communicate
  • Willing to participate and signing the informed consent form

Exclusion Criteria:

  • Spinal or extremity surgery or trauma within the last 6 months
  • Inflammatory rheumatic disease, radicular neurological signs (motor or reflex loss) or history of malignancy
  • Uncontrolled cardiovascular, pulmonary or neurological disease precluding exercise
  • Pregnancy
  • Physiotherapy/rehabilitation within the last 3 months or regular structured exercise ≥150 minutes per week
  • Planned job change or relocation during the study period

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Ergonomic training + structured exercise

Oil-field-specific ergonomic training (two 45-min sessions at weeks 1 and 6, brochure, weekly reminders) plus a 12-week phased neuromuscular and resistance exercise program, 3 days/week, 45 min/session, partly supervised at the worksite.

12 weeks, 3 non-consecutive days/week, 45 min/session (36 sessions). Weeks 1-2 fully supervised by a physiotherapist at the facility (groups of 4-6); weeks 3-12 one supervised + two home/worksite-based sessions per week with illustrated brochure and guided video. Three phases: motor control/activation (weeks 1-4, body weight and light bands), endurance/strength (weeks 5-8, medium bands, 5-8 kg), job-specific functional loading (weeks 9-12, heavy bands, 8-12 kg). Intensity Borg CR-10 4-6; progression by 2-for-2 rule; pain rule ≤3/10 during exercise returning to baseline within 24 h.

Comparador Ativo: Ergonomic training only (active control)

The same oil-field-specific ergonomic training (two 45-min sessions at weeks 1 and 6, brochure, weekly reminders) and a telephone call every 2 weeks for contact equalization; no exercise program during the study. The exercise program is offered after final assessment.

12 weeks, 3 non-consecutive days/week, 45 min/session (36 sessions). Weeks 1-2 fully supervised by a physiotherapist at the facility (groups of 4-6); weeks 3-12 one supervised + two home/worksite-based sessions per week with illustrated brochure and guided video. Three phases: motor control/activation (weeks 1-4, body weight and light bands), endurance/strength (weeks 5-8, medium bands, 5-8 kg), job-specific functional loading (weeks 9-12, heavy bands, 8-12 kg). Intensity Borg CR-10 4-6; progression by 2-for-2 rule; pain rule ≤3/10 during exercise returning to baseline within 24 h.

Two 45-minute face-to-face group sessions (8-12 workers) at weeks 1 and 6 delivered by a physiotherapist (short presentation, practical demonstration and teach-back, discussion). Content: oil-field musculoskeletal risk factors; NIOSH lifting principles; valve/flange and overhead work; vibrating tools and hand-arm vibration; prolonged standing, grated floors and stairs; vehicle/cabin and whole-body vibration; control-room/office ergonomics; shift schedules and sleep hygiene; 5-minute micro-break routine. Printed brochure and micro-break card; weekly reminder messages for 12 weeks.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in pain intensity (Visual Analogue Scale)
Prazo: Baseline, Week 12

Average pain over the past week marked on a 10 cm horizontal line (0 = no pain, 10 = worst imaginable pain), measured in cm. Lower scores indicate less pain. Minimal clinically important difference ≥2 cm or ≥30%.

Baseline, Week 12

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in pain-related disability (Pain Disability Index)
Prazo: Baseline, Week 12

7 items (family/home responsibilities, recreation, social activity, occupation, sexual behavior, self-care, life-support activity) each rated 0-10; total 0-70, higher scores indicate greater disability. Turkish version validated.

Baseline, Week 12
Change in health-related quality of life (SF-12)
Prazo: Baseline, Week 12

Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, each 0-100; higher scores indicate better quality of life. Turkish version validated.

Baseline, Week 12
Change in regional musculoskeletal symptom prevalence (Extended Nordic Musculoskeletal Questionnaire)
Prazo: Baseline, Week 12

Presence of symptoms (yes/no) in the last 7 days and last 12 months and activity limitation in nine body regions (neck, shoulders, upper back, lower back, elbows, wrists/hands, hips/thighs, knees, ankles/feet). Turkish version validated.

Baseline, Week 12
Change in sleep quality (Pittsburgh Sleep Quality Index) - exploratory
Prazo: Baseline, Week 12

Seven component scores (0-3) summed to a global score 0-21; scores >5 indicate poor sleep quality. Turkish version validated.

Baseline, Week 12

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Cadeira de estudo: Sedat Kartal, Üsküdar University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

15 de dezembro de 2026

Conclusão Primária (Estimado)

20 de maio de 2027

Conclusão do estudo (Estimado)

20 de maio de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

11 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de novembro de 2026

Primeira postagem (Real)

17 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Descrição do plano IPD

De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever